The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study.

[1]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[2]  Satoshi Konno,et al.  Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[3]  Donavan T. Cheng,et al.  Plasma Proteomic Profiling Of Baseline Biomarkers Associated With High Resolution CT (HRCT) In The TESRA Cohort , 2012, ATS 2012.

[4]  Marleen de Bruijne,et al.  Factors influencing the decline in lung density in a Danish lung cancer screening cohort , 2012, European Respiratory Journal.

[5]  L. Edwards,et al.  COPD association and repeatability of blood biomarkers in the ECLIPSE cohort , 2011, Respiratory research.

[6]  Warren B. Gefter,et al.  The n e w e n g l a n d j o u r n a l of m e d i c i n e , 2011 .

[7]  Nicola A Hanania,et al.  Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. , 2011, Radiology.

[8]  L. Edwards,et al.  Changes in forced expiratory volume in 1 second over time in COPD. , 2011, The New England journal of medicine.

[9]  L. Edwards,et al.  Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. , 2011, Academic radiology.

[10]  L. Edwards,et al.  Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. , 2011, American journal of respiratory and critical care medicine.

[11]  M. Bottai,et al.  Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study , 2011, Respiratory research.

[12]  D. Lynch,et al.  Epidemiology, radiology, and genetics of nicotine dependence in COPD , 2011, Respiratory research.

[13]  P. Calverley,et al.  Bias due to withdrawal in long‐term randomised trials in COPD: Evidence from the TORCH study , 2011, The clinical respiratory journal.

[14]  Edwin K Silverman,et al.  Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. , 2011, American journal of respiratory and critical care medicine.

[15]  Marleen de Bruijne,et al.  Short-term effect of changes in smoking behaviour on emphysema quantification by CT , 2010, Thorax.

[16]  S. Raposeiras-Roubín,et al.  Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels , 2010, European journal of heart failure.

[17]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[18]  Edwin K Silverman,et al.  Characterisation of COPD heterogeneity in the ECLIPSE cohort , 2010, Respiratory research.

[19]  R. Bowler,et al.  Polymorphisms in the Superoxide Dismutase-3 Gene Are Associated with Emphysema in COPD , 2010, COPD.

[20]  G. Washko,et al.  Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPD , 2010, European Respiratory Journal.

[21]  P. Paré,et al.  Prediction of the rate of decline in FEV1 in smokers using quantitative computed tomography , 2009, Thorax.

[22]  A. Dirksen,et al.  Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency , 2009, European Respiratory Journal.

[23]  L. Edwards,et al.  Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD , 2009, European Respiratory Journal.

[24]  Asger Dirksen,et al.  Monitoring the progress of emphysema by repeat computed tomography scans with focus on noise reduction. , 2008, Proceedings of the American Thoracic Society.

[25]  Yasutaka Nakano,et al.  Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[26]  L. Edwards,et al.  Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort , 2008, Thorax.

[27]  W. MacNee,et al.  Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) , 2008, European Respiratory Journal.

[28]  Johan H C Reiber,et al.  Progression parameters for emphysema: a clinical investigation. , 2007, Respiratory medicine.

[29]  B. Make,et al.  Genetic determinants of emphysema distribution in the national emphysema treatment trial. , 2007, American journal of respiratory and critical care medicine.

[30]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[31]  M. Kamran,et al.  Surfactant proteins SP-A and SP-D: structure, function and receptors. , 2006, Molecular immunology.

[32]  P. Gevenois,et al.  Pulmonary emphysema: objective quantification at multi-detector row CT--comparison with macroscopic and microscopic morphometry. , 2006, Radiology.

[33]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[34]  W. Bailey,et al.  Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.

[35]  H A Vrooman,et al.  A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. , 1999, American journal of respiratory and critical care medicine.

[36]  J. Hogg,et al.  Lung structure and function in cigarette smokers. , 1994, Thorax.

[37]  W. Thurlbeck.  Lung structure and function in cigarette smokers. , 1994, Thorax.

[38]  N. Müller,et al.  "Density mask". An objective method to quantitate emphysema using computed tomography. , 1988, Chest.

[39]  L. Hedlund,et al.  Computed tomography of the lung. Densitometric studies. , 1983, Radiologic clinics of North America.

[40]  R. Mauceri,et al.  Computed tomography of the lung. , 1978, Radiology.

[41]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.